Sairam Parthasarathy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sairam Parthasarathy has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Stuart F. Quan
Arizona Respiratory Center, University of Arizona, Tucson, AZ, USA; Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, MA, USA; Division of Sleep Medicine, Harvard Medical School, Boston, MA, USA
5 shared publicationsAlexandra Valentin
2 shared publicationsCristina Ambrogio
Section of Pulmonary, Critical Care, and Sleep Medicine, Southern Arizona VA Health Care System, Tucson, AZ 85723, USA
2 shared publications- Daniel Combs
Department of Pediatrics, University of Arizona, Tucson, AZ
2 shared publications Patricia L. Haynes
2 shared publicationsRohit Budhiraja
2 shared publications
Latest Publications
- 1 February 2016
- Published by Elsevier in Sleep Medicine
- Vol. 18, 61-66
Longitudinal differences in sleep duration in Hispanic and Caucasian children
- 1 February 2016
- Published by Elsevier in Sleep Medicine
- Vol. 18, 61-66
Longitudinal differences in sleep duration in Hispanic and Caucasian children
- 1 October 2015
- Published by Elsevier in The American Journal of Medicine
- Vol. 128 (10) , 1126-1137.e1
A Meta-analysis of Sleep-promoting Interventions During Critical Illness
- 1 October 2015
- Published by Elsevier in The American Journal of Medicine
- Vol. 128 (10) , 1126-1137.e1
A Meta-analysis of Sleep-promoting Interventions During Critical Illness
- 15 June 2015
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 11 (6) , 663-670
Retrospective Assessment of Home Ventilation to Reduce Rehospitalization in Chronic Obstructive Pulmonary Disease
Healthcare systems are attempting to reduce hospital readmissions due to chronic obstructive pulmonary disease (COPD). A retrospective study of a quality improvement (QI) program performed at a single center whose multifaceted intervention included nocturnal administration of advanced positive airway pressure (PAP) modality (or noninvasive positive pressure ventilation [NIPPV]) called averaged volume assured pressure support (AVAPS-AE) initiation by a respiratory therapist (RT), medication reconciliation by a pharmacist, adequate provision of oxygen, and ongoing RT-led care. In this QI program, consecutive patients who had been hospitalized twice in a single year with an acute COPD exacerbation underwent such interventions after they met specific selection criteria. Three-hundred ninety-seven consecutive patients were eligible for the program because they had two or more hospitalizations in the previous year. The proportion of patients who were readmitted on two or more occasions decreased from 100% (397 of 397) in the year prior to initiation of intervention to 2.2% (9 of 397) in the following year (χ(2) = 758, p < 0.0001). Seventy patients died over the one year following initiation of the multifaceted intervention. A composite outcome of rehospitalization and death was associated with inhaled steroids (adjusted odds ratio [adjOR] of 2.13; 95% confidence interval [CI] 1.09, 4.17; p = 0.02), whereas inhaled antimuscarinics tended to be associated with less risk for rehospitalization or death (adjOR 0.56; 95% CI 0.34, 1.03; p = 0.06). In a retrospective cohort study of a QI initiative undertaken at a single center, we have observed that a multifaceted intervention that involved initiation of nocturnal advanced PAP (NIPPV) modality, RT-led respiratory care, medication reconciliation, appropriate oxygen therapy initiation, and patient education led to significant reduction in rehospitalization.
- 15 June 2015
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 11 (6) , 663-670
Retrospective Assessment of Home Ventilation to Reduce Rehospitalization in Chronic Obstructive Pulmonary Disease
Healthcare systems are attempting to reduce hospital readmissions due to chronic obstructive pulmonary disease (COPD). A retrospective study of a quality improvement (QI) program performed at a single center whose multifaceted intervention included nocturnal administration of advanced positive airway pressure (PAP) modality (or noninvasive positive pressure ventilation [NIPPV]) called averaged volume assured pressure support (AVAPS-AE) initiation by a respiratory therapist (RT), medication reconciliation by a pharmacist, adequate provision of oxygen, and ongoing RT-led care. In this QI program, consecutive patients who had been hospitalized twice in a single year with an acute COPD exacerbation underwent such interventions after they met specific selection criteria. Three-hundred ninety-seven consecutive patients were eligible for the program because they had two or more hospitalizations in the previous year. The proportion of patients who were readmitted on two or more occasions decreased from 100% (397 of 397) in the year prior to initiation of intervention to 2.2% (9 of 397) in the following year (χ(2) = 758, p < 0.0001). Seventy patients died over the one year following initiation of the multifaceted intervention. A composite outcome of rehospitalization and death was associated with inhaled steroids (adjusted odds ratio [adjOR] of 2.13; 95% confidence interval [CI] 1.09, 4.17; p = 0.02), whereas inhaled antimuscarinics tended to be associated with less risk for rehospitalization or death (adjOR 0.56; 95% CI 0.34, 1.03; p = 0.06). In a retrospective cohort study of a QI initiative undertaken at a single center, we have observed that a multifaceted intervention that involved initiation of nocturnal advanced PAP (NIPPV) modality, RT-led respiratory care, medication reconciliation, appropriate oxygen therapy initiation, and patient education led to significant reduction in rehospitalization.
- 1 March 2015
- Published by Elsevier in The American Journal of Medicine
- Vol. 128 (3) , 268-275.e2
Persistent Insomnia is Associated with Mortality Risk
- 1 March 2015
- Published by Elsevier in The American Journal of Medicine
- Vol. 128 (3) , 268-275.e2
Persistent Insomnia is Associated with Mortality Risk
- 1 February 2015
- Published by Springer Nature in Current Pulmonology Reports
- Vol. 4 (1) , 42-55
Obesity hypoventilation syndrome
Obesity hypoventilation syndrome is a respiratory consequence of morbid obesity that is characterized by alveolar hypoventilation during sleep and wakefulness. The disorder involves a complex interaction between impaired respiratory mechanics, ventilatory drive, and sleep-disordered breathing. Early diagnosis and treatment is important because delay in treatment is associated with significant mortality and morbidity. Available treatment options include noninvasive positive airway pressure (PAP) therapies and weight loss. There is limited long-term data regarding the effectiveness of such therapies. This review outlines the current concepts of clinical presentation and diagnostic and management strategies to help identify and treat patients with obesity hypoventilation syndromes.
- 1 February 2015
- Published by Springer Nature in Current Pulmonology Reports
- Vol. 4 (1) , 42-55
Obesity hypoventilation syndrome
Obesity hypoventilation syndrome is a respiratory consequence of morbid obesity that is characterized by alveolar hypoventilation during sleep and wakefulness. The disorder involves a complex interaction between impaired respiratory mechanics, ventilatory drive, and sleep-disordered breathing. Early diagnosis and treatment is important because delay in treatment is associated with significant mortality and morbidity. Available treatment options include noninvasive positive airway pressure (PAP) therapies and weight loss. There is limited long-term data regarding the effectiveness of such therapies. This review outlines the current concepts of clinical presentation and diagnostic and management strategies to help identify and treat patients with obesity hypoventilation syndromes.
- 1 February 2015
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 38 (2) , 241-250
Cerebrovascular Reactivity in Young Subjects with Sleep Apnea
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.
- 1 February 2015
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 38 (2) , 241-250
Cerebrovascular Reactivity in Young Subjects with Sleep Apnea
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.
- 1 January 2015
- Published by Elsevier in The American Journal of Medicine
- Vol. 128 (1) , 10-13
Narcolepsy: Let the Patient's Voice Awaken Us!
- 1 January 2015
- Published by Elsevier in The American Journal of Medicine
- Vol. 128 (1) , 10-13
Narcolepsy: Let the Patient's Voice Awaken Us!
- 15 June 2013
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 9 (6) , 543-550
A Pilot Study of CPAP Adherence Promotion by Peer Buddies with Sleep Apnea
To evaluate patient ratings of the acceptability of a peer buddy system (PBS). To promote continuous positive airway pressure (CPAP) therapy adherence in patients with obstructive sleep apnea (OSA). To obtain preliminary data on the effectiveness of PBS on sleep-specific health-related quality of life and CPAP adherence. Prospective, randomized, and controlled study. Academic Center. Thirty-nine patients with OSA and 13 patients with OSA who were experienced CPAP users. Recently diagnosed patients with OSA were randomly assigned to either the PBS to promote CPAP adherence (intervention group) or usual care (control group). Patient satisfaction, Functional Outcomes of Sleep Questionnaire (FOSQ), CPAP adherence, vigilance, self-efficacy, and patient activation were measured. Ninety-one percent of the subjects rated the PBS as very satisfactory (68%) or satisfactory (23%). During the 90 days of therapy, weekly CPAP adherence was greater in the intervention than the usual care group (MANOVA; F = 2.29; p = 0.04). Patient satisfaction was positively correlated with CPAP adherence (R(2) = 0.14; p = 0.02). We did not find any group differences for FOSQ, vigilance, self-efficacy, or patient activation in this pilot study. Our pilot study suggests that the PBS intervention is feasible and received high patient satisfaction ratings. CPAP adherence may be improved by peer-driven intervention, but a larger, adequately powered study is needed. ClinicalTrials.gov identifier: NCT01164683. A commentary on this article appears in this issue on page 551. Parthasarathy S; Wendel C; Haynes PL; Atwood C; Kuna S. A pilot study of CPAP adherence promotion by peer buddies with sleep apnea. J Clin Sleep Med 2013;9(6):543-550.
- 15 June 2013
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 9 (6) , 543-550
A Pilot Study of CPAP Adherence Promotion by Peer Buddies with Sleep Apnea
To evaluate patient ratings of the acceptability of a peer buddy system (PBS). To promote continuous positive airway pressure (CPAP) therapy adherence in patients with obstructive sleep apnea (OSA). To obtain preliminary data on the effectiveness of PBS on sleep-specific health-related quality of life and CPAP adherence. Prospective, randomized, and controlled study. Academic Center. Thirty-nine patients with OSA and 13 patients with OSA who were experienced CPAP users. Recently diagnosed patients with OSA were randomly assigned to either the PBS to promote CPAP adherence (intervention group) or usual care (control group). Patient satisfaction, Functional Outcomes of Sleep Questionnaire (FOSQ), CPAP adherence, vigilance, self-efficacy, and patient activation were measured. Ninety-one percent of the subjects rated the PBS as very satisfactory (68%) or satisfactory (23%). During the 90 days of therapy, weekly CPAP adherence was greater in the intervention than the usual care group (MANOVA; F = 2.29; p = 0.04). Patient satisfaction was positively correlated with CPAP adherence (R(2) = 0.14; p = 0.02). We did not find any group differences for FOSQ, vigilance, self-efficacy, or patient activation in this pilot study. Our pilot study suggests that the PBS intervention is feasible and received high patient satisfaction ratings. CPAP adherence may be improved by peer-driven intervention, but a larger, adequately powered study is needed. ClinicalTrials.gov identifier: NCT01164683. A commentary on this article appears in this issue on page 551. Parthasarathy S; Wendel C; Haynes PL; Atwood C; Kuna S. A pilot study of CPAP adherence promotion by peer buddies with sleep apnea. J Clin Sleep Med 2013;9(6):543-550.
- 1 August 2012
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 35 (8) , 1029-1030
Sleep, Circadian Rhythms, and Critical Illness
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.
- 1 August 2012
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 35 (8) , 1029-1030
Sleep, Circadian Rhythms, and Critical Illness
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.
- 15 April 2012
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 8 (2) , 169-175
Refill Rates of Accessories for Positive Airway Pressure Therapy as a Surrogate Measure of Long-Term Adherence
To identify and validate a surrogate measure of long-term adherence to positive airway pressure (PAP) therapy in patients with obstructive sleep apnea (OSA). Retrospective cohort study. Academic center. 220 consecutive patients with OSA. N/A. In patients with OSA who were receiving PAP therapy (for > 1 year), PAP adherence measured by device-download and defined by Medicare criteria was compared to refill rates for mask and other PAP therapy accessories. First, receiver operating characteristic (ROC) curves were constructed to identify a threshold value of refills per year that discriminated best between PAP adherent and non-adherent patients (derivation set; n = 100). Then the predictive accuracy of the threshold value of refills per year was tested in an additional 120 consecutive patients (validation set). From the derivation set, ROC curve with good discriminant characteristics (ROC 0.83; 95% confidence intervals [CI], 0.75, 0.91, p < 0.0001) was used to identify a threshold value of refills (0.7 refills/year) for distinguishing PAP adherent and non-adherent patients. Subsequently, when the threshold was applied to the validation set, the likelihood ratio for a positive test (weighted for prevalence) predicting adherence to PAP therapy was 7.3 (95%CI, 3.8, 14), and likelihood ratio for a negative test was 0.6 (95%CI; 0.4, 0.8). Refill rate of PAP accessories exhibited good test characteristics for predicting long-term PAP adherence. Such a surrogate measure based upon insurance claims data can be a powerful epidemiological tool in bioinformatics-aided comparative-effectiveness research and to monitor clinical performance of health systems.
- 15 April 2012
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 8 (2) , 169-175
Refill Rates of Accessories for Positive Airway Pressure Therapy as a Surrogate Measure of Long-Term Adherence
To identify and validate a surrogate measure of long-term adherence to positive airway pressure (PAP) therapy in patients with obstructive sleep apnea (OSA). Retrospective cohort study. Academic center. 220 consecutive patients with OSA. N/A. In patients with OSA who were receiving PAP therapy (for > 1 year), PAP adherence measured by device-download and defined by Medicare criteria was compared to refill rates for mask and other PAP therapy accessories. First, receiver operating characteristic (ROC) curves were constructed to identify a threshold value of refills per year that discriminated best between PAP adherent and non-adherent patients (derivation set; n = 100). Then the predictive accuracy of the threshold value of refills per year was tested in an additional 120 consecutive patients (validation set). From the derivation set, ROC curve with good discriminant characteristics (ROC 0.83; 95% confidence intervals [CI], 0.75, 0.91, p < 0.0001) was used to identify a threshold value of refills (0.7 refills/year) for distinguishing PAP adherent and non-adherent patients. Subsequently, when the threshold was applied to the validation set, the likelihood ratio for a positive test (weighted for prevalence) predicting adherence to PAP therapy was 7.3 (95%CI, 3.8, 14), and likelihood ratio for a negative test was 0.6 (95%CI; 0.4, 0.8). Refill rate of PAP accessories exhibited good test characteristics for predicting long-term PAP adherence. Such a surrogate measure based upon insurance claims data can be a powerful epidemiological tool in bioinformatics-aided comparative-effectiveness research and to monitor clinical performance of health systems.